Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated 24 minutes ago

Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised

28 minutes ago

Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation...

Orphan designation: copper metabolism disorder Treatment of Wilson's disease, 20/05/2026 Positive

about 4 hours ago

Orphan designation: copper metabolism disorder Treatment of Wilson's disease, 20/05/2026 Positive

Orphan designation: quemliclustat Treatment of pancreatic cancer, 20/05/2026 Positive

about 4 hours ago

Orphan designation: quemliclustat Treatment of pancreatic cancer, 20/05/2026 Positive

Orphan designation: serabelisib Treatment of PIK3CA related overgrowth spectrum, 20/05/2026 Positive

about 4 hours ago

Orphan designation: serabelisib Treatment of PIK3CA related overgrowth spectrum, 20/05/2026 Positive

Orphan designation: alixorexton Treatment of narcolepsy, 20/05/2026 Positive

about 4 hours ago

Orphan designation: alixorexton Treatment of narcolepsy, 20/05/2026 Positive

EMA risk management information day

about 3 hours ago

EMA risk management information day

Clinical Trial Information System (CTIS) - Sponsor handbook

about 4 hours ago

Clinical Trial Information System (CTIS) - Sponsor handbook

New Zealand

about 8 hours ago

New Zealand

International arrangements

about 8 hours ago

International arrangements

Orphan designation: antisense oligonucleotide against USH2A pre-mRNA Treatment of inherited retinal disease due to dysfunction in the USH2A gene, 20/05/2026 Positive

about 4 hours ago

Orphan designation: antisense oligonucleotide against USH2A pre-mRNA Treatment of inherited retinal disease...